Skip to content

The effect of neuromuscular electrostimulation on muscle strenghthening of the m. quadriceps and on physical performance in frail elderly with poor physical performance on <= day 4 of hospital admission. Pilot study.

The effect of neuromuscular electrostimulation on muscle strenghthening of the m. quadriceps and on physical performance in frail elderly with poor physical performance on <= day 4 of hospital admission. Pilot study. - Effect NMES on physical performance in frail elderly during hospitalization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40231
Enrollment
30
Registered
2014-06-06
Start date
2014-09-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fysieke inactiviteit en sarcopenie door verscheidene oorzaken age and disease related muscle waekness Sarcopenia

Interventions

Application of NMES 5 days a week for 60 minutes a day during at least 1 week.

Sponsors

Orbis Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Frail elderly, 70 years and above, with a SPPB

Exclusion criteria

Exclusion criteria: - Bound to a wheelchair before admission - Terminal illness - Pain in the lower body which makes mobilisation impossible - No recovery of the underlying illness on day 4 of admission in comparison with the first day after admission - Presence of a pacemaker or ICD - Impossibility to give the patient instructions concerning the NMES and his measurements

Design outcomes

Primary

MeasureTime frame
Short physical performance battery HABAM Knee extension Measurement of muscle mass of the upper legs measured with the Maltron Bioscan 920-II

Secondary

MeasureTime frame
Tolerance of NMES and side effects. Admission time in days Destination of dismissal; home or to a health facility Mortality

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)